Get the Stockscreener App
10.50
3.75%
0.38
After Hours:
10.50
Immucell Corp stock is traded at $10.50, with a volume of 66,686.
It is up +3.75% in the last 24 hours and up +25.67% over the past month.
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
See More
Previous Close:
$10.12
Open:
$10.17
24h Volume:
66,686
Relative Volume:
2.88
Market Cap:
$94.99M
Revenue:
$27.64M
Net Income/Loss:
$-1.04M
P/E Ratio:
-92.35
EPS:
-0.1137
Net Cash Flow:
$1.22M
1W Performance:
+2.94%
1M Performance:
+25.67%
6M Performance:
+118.75%
1Y Performance:
+61.04%
1-Day Range:
$10.17
$10.75
1-Week Range:
$9.61
$10.75
52-Week Range:
$4.52
$10.75
Immucell Corp Stock (ICCC) Company Profile
Name
Immucell Corp
Sector
Industry
Phone
(207) 878-2770
Address
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
10.50 | 91.55M | 27.64M | -1.04M | 1.22M | -0.1137 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immucell Corp Stock (ICCC) Latest News
ImmuCell Shares Rose Ahead of Holiday; Tuesday’s Open in Focus - Bez Kabli
ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand - Yahoo Finance
ICCC SEC FilingsImmucell 10-K, 10-Q, 8-K Forms - Stock Titan
ICCC Technical Analysis | Trend, Signals & Chart Patterns | IMMUCELL CORP (NASDAQ:ICCC) - ChartMill
ImmuCell Corporation (NASDAQ:ICCC) Q1 2026 Earnings Call Transcript - Insider Monkey
ImmuCell Q1 Earnings Call Highlights - sharewise.com
Earnings call transcript: ImmuCell Q1 2026 marks milestone with revenue surge - Investing.com
ImmuCell (NASDAQ: ICCC) posts strong Q1 2026 growth, higher margins and cash - Stock Titan
ImmuCell (NASDAQ: ICCC) grows Q1 2026 revenue 28% and boosts earnings - Stock Titan
Calf-health maker ImmuCell secures $2M to expand First Defense output - Stock Titan
ImmuCell Corporation 2025 10-K/A Annual Report Filing Details, Address, and SEC Cover Information - Minichart
ImmuCell (NASDAQ: ICCC) files 10-K amendment to update exhibit list - Stock Titan
Here’s Why ImmuCell Corporation (ICCC) is Emerging as an Intriguing Micro-Cap Opportunity - Yahoo Finance
TradingKey - TradingKey
ImmuCell | 4: Statement of changes in beneficial ownership of securities-Director Basse Gloria F - Moomoo
ImmuCell Corporation Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Key Entity Information - Minichart
[8-K] IMMUCELL CORP /DE/ Reports Material Event - Stock Titan
ImmuCell keeps Q1 sales outlook unchanged ahead of May 15 results call - Stock Titan
Short Interest in ImmuCell Corporation (NASDAQ:ICCC) Decreases By 20.8% - MarketBeat
ImmuCell (NASDAQ:ICCC) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
The Christmas party is still ongoing in these stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - MSN
ImmuCell (NASDAQ: ICCC) outlines 2026 strategy, equity plan and pay - Stock Titan
ImmuCell (ICCC) director discloses 17,899 stock options grant details - Stock Titan
ImmuCell (NASDAQ: ICCC) director lists 17,899 stock options - Stock Titan
ImmuCell : Corporate Presentation (Investor Relations April 2026 Final) - marketscreener.com
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell - Zacks Investment Research
ICCC (ImmuCell Corporation) rises 1.78 percent after posting a 0.31 dollar per share loss for Q4 2025.Elite Trading Signals - newser.com
ICCC ImmuCell Corporation shares gain nearly two percent following release of its Q4 2025 earnings report.Revenue Growth - newser.com
[Form 4] IMMUCELL CORP /DE/ Insider Trading Activity - Stock Titan
ImmuCell (ICCC) grants director 11,933 stock options at $7.60 - Stock Titan
Director Gloria Basse granted 11,933 ImmuCell (ICCC) stock options - Stock Titan
ImmuCell (ICCC) director Paul Wainman receives 11,933 stock options at $7.60 - Stock Titan
650K-share equity plan and officer exculpation up for vote — ImmuCell (NASDAQ: ICCC) - Stock Titan
ImmuCell (ICCC) VP Brockmann granted 5,000 incentive stock options - Stock Titan
ImmuCell (ICCC) director receives grant of 10,000 stock options - Stock Titan
ImmuCell (ICCC) director awarded 10,000 stock options at $5.49 strike - Stock Titan
ImmuCell (ICCC) director awarded 10,000 options at $5.49 exercise price - Stock Titan
ImmuCell (ICCC) director Steven Rosgen granted 10,000 stock options at $5.49 - Stock Titan
ImmuCell (ICCC) director receives 10,000 non-qualified stock options at $5.49 - Stock Titan
ImmuCell (ICCC) adds industry veterans to a smaller, more independent board - Stock Titan
ImmuCell appoints two directors, expands to 7-member board - Investing.com
ImmuCell appoints two directors, expands to 7-member board By Investing.com - Investing.com South Africa
Two animal health veterans join ImmuCell as board shrinks to 7 - Stock Titan
Is ImmuCell Corporation (ICCC) Stock undervalued by the market | Price at $7.26, Up 13.79%Wall Street Picks - Newser
Immucell Corp Stock (ICCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Immucell Corp Stock (ICCC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| te Boekhorst Paul Francis Oliv | President and CEO |
Dec 03 '25 |
Buy |
5.02 |
6,077 |
30,536 |
9,785 |
| te Boekhorst Paul Francis Oliv | President and CEO |
Dec 02 '25 |
Buy |
4.87 |
3,708 |
18,053 |
3,708 |
| Tomsche David Scott | Director |
Nov 25 '25 |
Buy |
4.76 |
1,633 |
7,781 |
4,740 |
| Tomsche David Scott | Director |
Nov 25 '25 |
Buy |
4.76 |
1,633 |
7,773 |
52,720 |
| Basse Gloria F | Director |
Jun 11 '25 |
Option Exercise |
4.81 |
3,530 |
16,979 |
3,530 |
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):